VEGF as a mediator of tumor-associated immunodeficiency (original) (raw)

• Kayanaugh DY, Carbone DP: Immunologic dysfunction in cancer. Hematol-Oncol Clin, North America 1996;10:927–951.
  Article Google Scholar
• Johnsen AK, Templeton DJ, Sy M, Harding CV: Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis. J Immunol 1999;163:4224–4231.
  PubMed CAS Google Scholar
• Finke J, Ferrone S, Frey A, Mufson A, Ochoa A: Where have all the T cells gone? Mechanisms of immune evasion by tumors. Immunol Today 1999;20:158–160.
  Article PubMed CAS Google Scholar
• Antonia SJ, Extermann M, Flavell RA: Immunologic nonresponsiveness to tumors. Crit Rev Oncog 1998;9:35–41.
  PubMed CAS Google Scholar
• Kiessling R, Wasserman K, Horiguchi S et al.: Tumor-induced immune dysfunction. Cancer Immunol Immunother 1999;48:353–362.
  Article PubMed CAS Google Scholar
• Shu S, Plautz GE, Krauss JC, Chang AE: Tumor immunology. JAMA 1997;278:1972–1981.
  Article PubMed CAS Google Scholar
• Pawelec G, Zeuthen J, Kiessling R: Escape from host-antitumor immunity. Crit Rev Oncog 1997; 8:111–141.
  PubMed CAS Google Scholar
• Markiewicz MA, Gajewski TF: The immune system as anti-tumor sentinel: molecular requirements for an anti-tumor immune response. Crit Rev Oncog 1999;10:247–260.
  PubMed CAS Google Scholar
• Ferrara N, Carver-Moore K, Chen H, et al.: Heterozy gous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996;380:439–442.
  Article PubMed CAS Google Scholar
• Ferrara N, Davis-Smyth, T: The Biology of Vascular Endothelial Growth Factor. Endocrine Rev 1997;18:4–25.
  Article CAS Google Scholar
• Toi M, Hoshina S, Takayanagi T, Tominaga T: Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 1994;85:1045–1049.
  PubMed CAS Google Scholar
• Toi M, Taniguchi T, Yamamoto Y, Kurisaki T, Suzuki H, Tominaga T: Clinical significance of the determination of angiogenic factors. Eur J Cancer 1996;32A:2513–2519.
  Article PubMed CAS Google Scholar
• Ziegler BL, Valtieri M, Porada GA, et al.: KDR receptor: a key marker defining hematopoietic stem cells. Science 1999;285:1553–1558.
  Article PubMed CAS Google Scholar
• Gabrilovich DI, Chen HL, Girgis KR, et al.: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature Med 1996;2:1096–1103.
  Article PubMed CAS Google Scholar
• Gabrilovich D, Ishida T, Oyama T, et al.: Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 1998;92:4150–4166.
  PubMed CAS Google Scholar
• Ishida T, Oyama T, Carbone DP, Gabrilovich DI: Defective function of Langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors. J Immunol 1998;161:4842–4851.
  PubMed CAS Google Scholar
• Oyama T, Ran S, Ishida T, et al.: Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. J Immunol 1998;160:1224–1232.
  PubMed CAS Google Scholar
• Boon T: Towarda genetic analysis of tumor rejection antigens. Adv Cancer Res 1992;58:177–210.
  Article PubMed CAS Google Scholar
• Boon T, van der Bruggen P: Human tumor antigens recognized by T lymphocytes. J Exp Med 1996; 183:725–729.
  Article PubMed CAS Google Scholar
• Boon T, Cerottini J-C, Van der Eynde B, Van Der Bruggen P, Van Pel A: Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 1994;12:337–365.
  Article PubMed CAS Google Scholar
• Ciernik IF, Carbone DP: Tumor Suppressor Gene-Derived Peptide Antigens. Meth Enzymol 1995; 8:225–233.
  Article CAS Google Scholar
• Coulie PG, Lehmann F, Lethe B, et al.: A mutated intron sequence codes foran antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc Natl Acad Sci USA 1995;92:7976–7980.
  Article PubMed CAS Google Scholar
• Van Pel A, De Plaen E, Lurquin C, et al.: Identification of genes encoding T cell defined tumantigens. Int Symp Princess Takamatsu Cancer Res Fund 1988;19:255–263.
  PubMed Google Scholar
• Alcalay J, Kripke ML: Antigen-presenting activity of draining lymph node cells from mice painted with a contact allergen during ultraviolet carcinogenesis. J Immunol 1991;146:1717–1721.
  PubMed CAS Google Scholar
• Erroi A, Sironi M, Chiaffarino F, Chen ZG, Mengozzi M, Mantovani A: IL1 and IL6 released by tumor-associated macrophages from human ovarian carcinoma. Int J Cancer 1989;41:65–68.
  Article Google Scholar
• Watson GA, Lopez DM: Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses. J Immunol 1995;155:3124–3134.
  PubMed CAS Google Scholar
• Gabrilovich DI, Nadaf S, Corak J, Berzofsky JA, Carbone DP: Dendritic cells in anti-tumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice are effective antigen carriers in the therapy of established tumors. Cell Immunol 1996; 170:111–119.
  Article PubMed CAS Google Scholar
• Ferrara N Houck K, Jakeman L, Leung DW: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrine Rev 1992;13:18–32.
  Article CAS Google Scholar
• Kondo S, Asano M, Matsuo K, Ohmori I, Suzuki H: Vascular endothelial growth factor/vascular pemeability factor is detectable in thesera of tumor-bearing mice and cancer patients. Bioch Biophys Acta 1994;1221:211–214.
  Article CAS Google Scholar
• Ellis LM, Fidler IJ: Angiogenesis and metastasis. Eur J Cancer 1996;32A:2451–2460.
  Article PubMed CAS Google Scholar
• Hoehn GT, Stokland T, Amin S, et al.: Tnk1: a novel intracellular tyrosine kinase gene isolated from human umbilical cord blood CD34+/Lin-/CD38-stem/progenitor cells. Oncogene 1996;12:440–448.
  Google Scholar
• Katoh O, Tauchi H, Kawaishi K, Kimura A, Satow Y: Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoetic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res 1995;55:5687–5692.
  PubMed CAS Google Scholar
• Broxmeyer HE, Cooper S, Li ZH, et al.: Myeloid progenitor cells regulatory effects of vascular endothelial cell growth factor. Inter J Hematol 1995;62:203–215.
  Article CAS Google Scholar
• Almand B, Resser JR, Lindman B, et al.: Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res 2000;6:1755–1766.
  PubMed CAS Google Scholar
• Gabrilovich DI, Ishida T, Nadaf S, Ohm JE, Carbone DP: Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function. Clin Cancer Res 1999;5:2963–2970.
  PubMed CAS Google Scholar
• Grossmann M, Nakamura Y, Grumont R, Gerondakis S: New insights into the roles of ReL/NF-kappa B transcription factors in immune function, hemopoiesis and human disease. Int J Biochem Cell Biol 1999;31:1209–1219.
  Article PubMed CAS Google Scholar
• Ghosh S, May MJ, Kopp EB: NF-kappa B and Re1 proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16:225–260.
  Article PubMed CAS Google Scholar
• Wulczyn FG, Krappmann D, Scheidereit C: The NF-kappa B/Re1 and 1 kappa B gene families: mediators of immune response and inflammation. J Mol Med 1996;74:749–769.
  Article PubMed CAS Google Scholar
• Baeuerle PA, Henkel T: Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994;12:141–179.
  PubMed CAS Google Scholar
• Stankovski I, Baltimore, D: NF-κB Activation: The IκB Kinase Revealed. Cell 1997;91:299–302.
  Article Google Scholar
• Thanos D, Maniatis T: NF-κB: A Lesson in Family Values. Cell 1995;80:529–532.
  Article PubMed CAS Google Scholar
• Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S: Re1/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev 1995;9:2723–2735.
  Article PubMed CAS Google Scholar
• Baeuerle PA, Baltimore D: NF-kappa B: ten years after. Cell 1996;87:13–20.
  Article PubMed CAS Google Scholar
• Baldwin AS: The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996;14:649–683.
  Article PubMed CAS Google Scholar
• Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999;13:9–22.
  PubMed CAS Google Scholar
• Hiratsuka S, Minowa O, Kuno J, Noda T, Shibuya M: Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci USA 1998;95:9349–9354.
  Article PubMed CAS Google Scholar